+43.0%
GSK vs STLA
-75.4%
+118.4%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | STLA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.3% | -1.9% | -0.4% | -2.1% |
| 7D | -3.0% | -14.6% | +11.5% | -1.3% |
| 30D | +0.4% | -16.7% | +17.1% | +2.3% |
| 3M | -1.2% | -28.9% | +27.7% | +2.5% |
| 6M | +0.9% | -51.4% | +52.3% | +9.5% |
| YTD | +4.0% | -66.6% | +70.6% | +17.3% |
| 1Y | +7.3% | -63.5% | +70.8% | +19.5% |
| 3Y | +57.1% | -79.1% | +136.1% | +85.7% |
| 5Y | +43.0% | -75.4% | +118.4% | +58.8% |
| All | +43.0% | -75.4% | +118.4% | +58.8% |
Cumulative growth
Daily Returns
Daily percentage return beside STLA.
Daily Out/Under-Performance
Portfolio return minus STLA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × STLA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded STLA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling